L, L., Y, W., X, H., Z, L., M, L., T, G., . . . C, T. (2022). Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma. Frontiers in immunology, 13, 879560. https://doi.org/10.3389/fimmu.2022.879560
Chicago Style (17th ed.) CitationL, Li, et al. "Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma." Frontiers in Immunology 13 (2022): 879560. https://doi.org/10.3389/fimmu.2022.879560.
MLA (9th ed.) CitationL, Li, et al. "Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma." Frontiers in Immunology, vol. 13, 2022, p. 879560, https://doi.org/10.3389/fimmu.2022.879560.